M

Middle East Pharmaceutical Industries Company SJSC
SAU:4016

Watchlist Manager
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Watchlist
Price: 121.2 SAR 1.68% Market Closed
Market Cap: 2.4B SAR
Have any thoughts about
Middle East Pharmaceutical Industries Company SJSC?
Write Note

Middle East Pharmaceutical Industries Company SJSC
Accumulated Depreciation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Middle East Pharmaceutical Industries Company SJSC
Accumulated Depreciation Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accumulated Depreciation CAGR 3Y CAGR 5Y CAGR 10Y
M
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Accumulated Depreciation
-ď·Ľ72.5m
CAGR 3-Years
-11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
SAU:2070
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jamjoom Pharmaceuticals Factory Company SJSC
SAU:4015
Accumulated Depreciation
-ď·Ľ406.2m
CAGR 3-Years
-6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Middle East Pharmaceutical Industries Company SJSC
Glance View

Market Cap
2.4B SAR
Industry
Pharmaceuticals

Middle East Pharmaceutical Industries Company SJSC is a SA-based company operating in Pharmaceuticals industry. The company is headquartered in Riyadh, Riyadh and currently employs 335 full-time employees. The company went IPO on 2024-02-27. Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The firm develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.

Intrinsic Value
88.32 SAR
Overvaluation 27%
Intrinsic Value
Price
M

See Also

What is Middle East Pharmaceutical Industries Company SJSC's Accumulated Depreciation?
Accumulated Depreciation
-72.5m SAR

Based on the financial report for Dec 31, 2023, Middle East Pharmaceutical Industries Company SJSC's Accumulated Depreciation amounts to -72.5m SAR.

What is Middle East Pharmaceutical Industries Company SJSC's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 3Y
-11%

Over the last year, the Accumulated Depreciation growth was -11%. The average annual Accumulated Depreciation growth rates for Middle East Pharmaceutical Industries Company SJSC have been -11% over the past three years .

Back to Top